ASAntonio Sitges-Serra

Antonio Sitges-Serra

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Antonio Sitges-Serra has a total of 38 co-authors. Here are the top co-authors by number of shared publications:

  • Joan J. Sancho

    Endocrine Surgery Unit Hospital del Mar Barcelona Spain

    5 shared publications
  • Jaime Jimeno

    Endocrine Surgery Unit Hospital del Mar Barcelona Spain

    3 shared publications
  • Estela Membrilla

    Department of Surgery, Endocrine Surgery Unit, Hospital del Mar, Barcelona, Spain

    2 shared publications
  • José A. Pereira

    Department of Surgery, Endocrine Surgery Unit, Hospital del Mar, Barcelona, Spain

    2 shared publications
  • Meritxell Girvent

    Facultat de Cièncias de la Salut i de la Vida, Universitat Pompeu Fabra Hospital del Mar P° Marítim, 25‐29 08003 Barcelona Spain

    2 shared publications
  • Xavier Nogués

    Internal Medicine Department, Hospital del Mar Research Institute, CIBERFES, Universitat Pompeu Fabra, Barcelona, Spain

    2 shared publications

Latest Publications

  • Open Access

    Effect of parathyroidectomy for primary hyperparathyroidism on bone mineral density in postmenopausal women

    by A Sitges-Serra, L García, R Prieto, M J Peña, X Nogués, J J Sancho

    Background: The bone mineral density (BMD) response to parathyroidectomy is heterogeneous and difficult to predict. Available data come from mixed populations of men and women, of different age and degrees of disease severity, and preoperative BMD loss. Methods: This was a longitudinal, prospective cohort study of 103 postmenopausal women with osteopenia or osteoporosis at the femoral neck site, successfully operated on for primary hyper parathyroidism. BMD and metabolic variables were recorded before and 1 year after parathyroidectomy. Results: After surgery, there was a 1·3 per cent increase in the median BMD at the femoral neck site (0·615 versus 0·623 g/cm2; P = 0·001). Overall, positive responses were also observed at total hip (0·4 per cent) and lumbar spine (2·3 per cent) sites. Analysing the individual responses, however, only 45 (46 per cent) of 97 patients showed a significant (at least 3·7 per cent) increase in BMD at the femoral neck site compared with the preoperative value and 52 had a decreased (15) or unchanged (37) femoral neck BMD. Patients who gained BMD were younger, had more severe hyperparathyroidism and better renal function. Conclusion: Almost half of the postmenopausal women with hyperparathyroidism and low BMD have a significant remineralization response 1 year after parathyroidectomy. Differential mineralization responses of BMD after surgery appear to be related to severity of primary hyperparathyroidism, age and renal function.


  • Weight Difference Between Double Parathyroid Adenomas Is the Cause of False‐positive IOPTH Test After Resection of the First Lesion

    by Antonio Sitges‐Serra, Francisco Javier Díaz‐Aguirregoitia, Aitor de la Quintana, Jesús Gil‐Sánchez, Jaime Jimeno, Rosa Prieto, Joan J. Sancho

    Background Some patients with double parathyroid adenoma show a greater than 50% decline in intraoperative parathyroid hormone (IOPTH) after resection of the first lesion. The present study was designed to test the hypothesis that significant adenoma weight differences may explain this inappropriate decline of IOPTH. Methods We reviewed prospective database records at two tertiary institutions. Patients with a histopathologic diagnosis of double adenoma and no familial history of hyperparathyroidism were included. Diagnosis of double adenoma was confirmed either preoperatively (double uptake), intraoperatively (bilateral exploration), or at reintervention. IOPTH was determined following the Miami protocol. The 10-min postexcision sample was considered as the 0-min sample for IOPTH determinations at the time of resection of the second lesion. Results Thirteen patients met the inclusion criteria. After resection of the first lesion, IOPTH failed to decline in four patients and a second adenoma was removed. They had similar weight (404 vs. 598 mg). In nine patients IOPTH showed a false greater than 50% decline. These patients had the largest adenoma removed first (846 ± 226 mg), and only two had normal PTH serum concentrations 10 min after resection. The second adenoma was always smaller (284 ± 177 mg; P = 0.02) and its resection either during the same operation (7 cases) or at reoperation (2 cases) led to normalization of IOPTH at 10 min in all cases. Conclusions Two-thirds of patients with double parathyroid adenoma show a false-positive decline of IOPTH after resection of the first adenoma. This appears to be due to the initial removal of the larger lesion.


  • Surgical strategy for sporadic primary hyperparathyroidism an evidence-based approach to surgical strategy, patient selection, surgical access, and reoperations

    by Radu Mihai, Marcin Barczynski, Maurizio Iacobone, Antonio Sitges-Serra

    Progress in parathyroid imaging has brought substantial changes in the surgical strategy to approach patients with sporadic primary hyperparathyroidism (pHPT). The present review is focused on the safety and efficacy of limited parathyroid exploration. Review of the literature focused on studies dealing with unilateral (two-gland exploration) or selective parathyroidectomy (one-gland exploration) in selected patients with pHPT and on the classification of published reports according to the degree of evidence. Parathyroid exploration limited to a solitary parathyroid adenoma can be considered a minimally invasive procedure that can be performed by the minicervicotomy, video-assisted, or endoscopic approaches. In properly selected patients, it affords results comparable to those of four-gland bilateral exploration in terms of cure and recurrence. It causes less postoperative hypocalcemia. Selective parathyroidectomy is an option for patients with positive preoperative localization tests undergoing first-time surgery who have no family history of pHPT, no goiter for which surgical therapy is proposed, and are not on lithium therapy.


  • Surgery for sporadic primary hyperparathyroidism: controversies and evidence-based approach

    by Antonio Sitges-Serra, Prieto Rosa, Mónica Valero, Estela Membrilla, Joan J. Sancho

    Introduction Sporadic primary hyperparathyroidism is due to single adenoma in over 90–95% of instances. Careful medical history and precise preoperative identification of the enlarged gland by parathyroid Tc-mibi scintigraphy and neck ultrasound allow selecting patients for minimally invasive parathyroidectomy, a focused intervention with minimal skin opening and tissue dissection. Small (<300 mg) adenomas continue to challenge preoperative imaging, and most of them will still require a bilateral exploration. Conclusion Surgery should never be indicated on the basis of positive or negative preoperative localization studies. Intraoperative quick parathyroid hormone measurements seem particularly helpful for cases with equivocal localization studies. The best minimal access approach is still a matter of debate, and options include small central incision, video-assisted parathyroidectomy, minimal lateral open approach, and purely endoscopic access via lateral approach. Radioguided surgery does not seem to have a role in routine cases but may be useful to find adenomas during reintervention on scarred difficult surgical fields.


  • Clinical update: sporadic primary hyperparathyroidism

    by Antonio Sitges-Serra, Anders Bergenfelz


  • Usefulness of preoperative Tc-mibi parathyroid scintigraphy in secondary hyperparathyroidism

    by Alberto de la Rosa, Jaime Jimeno, Estela Membrilla, Joan J. Sancho, José A. Pereira, Antonio Sitges-Serra


  • Open Access

    Increased Mortality and Morbidity Associated With Thyroidectomy for Intrathoracic Goiters Reaching the Carina Tracheae

    by Joan J. Sancho, Jean L. Kraimps, Jose M. Sanchez-Blanco, Alvaro Larrad, Jose M. Rodríguez, Pedro Gil, Helene Gibelin, Jose A. Pereira, Antonio Sitges-Serra

    Research from JAMA Surgery — Increased Mortality and Morbidity Associated With Thyroidectomy for Intrathoracic Goiters Reaching the Carina Tracheae


  • Open Access

    Multivariate analysis of factors associated with renal dysfunction in patients with obstructive jaundice

    by F J Padillo, A Cruz, J Briceño, A Martin-Malo, C Pera-Madrazo, A Sitges-Serra

    Background: The aim was to evaluate the factors determining preoperative renal dysfunction in patients with obstructive jaundice. Methods: In a prospective cross-sectional observational study, 63 patients, 27 with benign and 36 with malignant obstructive jaundice, were investigated at admission and compared with 25 healthy control subjects. Variables analysed included extracellular body water (ECW) compartment, plasma levels of aldosterone, renin, atrial natriuretic peptide, vasopressin, nitric oxide, endothelin (ET) 1 and prostaglandin E2 (PGE2), urinary nitric oxide and PGE2, serum albumin and renal function. Results: The metabolic profile of obstructive jaundice was characterized by a depletion of the ECW (P = 0·004), and increased plasma levels of atrial natriuretic peptide (P < 0·001), ET-1 (P = 0·044), vasopressin (P = 0·017), aldosterone (P = 0·005) and renin (P = 0·001). Increased plasma (P < 0·001) and urinary (P = 0·001) PGE2 levels were also found. Fifty-four per cent of patients had a creatinine clearance of less than 70 ml/min. In multivariate analysis, serum bilirubin, renin, ET-1, PGE2, decreased urinary sodium excretion and age were identified as predictors of renal dysfunction. Conclusions: Renal dysfunction in patients with obstructive jaundice was associated with the degree of biliary obstruction, age of the patient and reduced urinary sodium excretion. These alterations were closely related to derangements in sodium- and water-regulating hormones.


  • Bone Mineral Density in Menopausal Women with Primary Hyperparathyroidism before and after Parathyroidectomy

    by Antonio Sitges‐Serra, Meritxell Girvent, José A. Pereira, Jaime Jimeno, Xavier Nogués, Francisco J. Cano, Joan J. Sancho

    The relationship between osteoporosis and primary hyperparathyroidism (pHPT) has not been definitely established because both diseases occur predominantly in postmenopausal women, and because PTH has a paradoxical effect on bone. We have investigated the prevalence of reduced bone mineral density (BMD) in women with pHPT, its relationship with metabolic parameters, and its course after parathyroidectomy. A prospective observational study was carried out on perimenopausal and postmenopausal women consecutively diagnosed and operated on for pHPT. Demographic data were recorded, as well as, PTH, Ca, calciuria/24h, P, vitamin D, adenoma weight. The BMD was measured at three sites: femoral neck (FN), proximal femur (PF), and lumbar spine (LS). Fifty-two patients were included with a mean age of 61 ± 12 years. The prevalence of reduced BMD (≤ 1SD, T-score) was 80%–100% depending on site. Parathyroid hormone was higher in patients with osteoporosis (319 ± 181 pg/ml) than in those with osteopenia (230 ± 83 pg/ml) or normal BMD (148 ± 81 pg/ml; p < 0,04). Twenty-eight patients were investigated 1 year after parathyroidectomy. The BMD improved significantly at all sites, particularly in patients with osteoporosis. Age correlated inversely with BMD increases at the femoral sites (r= –0,47; p = 0,02) but not at the LS. 25-OHD3 plasma levels correlated inversely with BMD increases at PF (r= –0,76; p < 0,0001). In pHPT, there is a high prevalence of BMD abnormalities. No metabolic variables had a definite influence on BMD values but a tendency was observed for lower BMD in severe pHPT. One year after parathyroidectomy, there were significant BMD increases that were more marked at femoral sites, in younger patients, in patients with preoperative osteoporosis, and in those with lower plasma levels of 25-OHD3.